
Trioar
Developer of drugs designed to improve the limitations of antibody therapeutics and antibody-drug conjugates. The company's drugs detect cancer lesions so that they are absorbed quickly and specifical...
Valuation
$0
Share Price
N/A
Total Raised
$33M
Last Round
N/A